Zobrazeno 1 - 10
of 73
pro vyhledávání: '"A. Armengol-Alonso"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
León-Maldonado, Leith, López-Olmedo, Nancy, Murillo, Raúl, Hurtado-Salgado, Erika, Allen-Leigh, Betania, Armengol-Alonso, Alejandra, Torres-Mejía, Gabriela, Bautista-Arredondo, Sergio, Barrientos-Gutiérrez, Tonatiuh, Lazcano-Ponce, Eduardo
Publikováno v:
Salud Pública de México; jul/ago2024, Vol. 66 Issue 4, p547-554, 8p
Autor:
Rivera Duarte, Alfonso, Armengol Alonso, Alejandra, Sandoval Cartagena, Elena, Tuna Aguilar, Elena
Publikováno v:
In Clinical Lymphoma Myeloma and Leukemia August 2017 17(8):532-538
Autor:
Monica M. Rivera Franco, Eucario Leon Rodriguez, Braulio Martinez Benitez, Luisa G. Villanueva Rodriguez, Maria de la Luz Sevilla Gonzalez, Alejandra Armengol Alonso
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 2016, Iss 10, Pp 177-184 (2016)
Externí odkaz:
https://doaj.org/article/d0c27de9b42b49e1ba904122f9c15784
Publikováno v:
In The Breast December 2014 23(6):710-720
Autor:
M. M. Rivera-Franco, J. Alberú-Gómez, P. Merchan-Alvear, E. Leon-Rodriguez, A. Armengol-Alonso
Publikováno v:
Clinical and Translational Oncology. 22:1796-1801
To report the incidence of cancer after renal transplantation at a referral center in a developing country. Consecutive patients receiving renal transplantations during a 48-year period at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Z
Autor:
Nancy Reynoso-Noverón, FM Villalobos-Castaldi, Alejandro Mohar, Enrique Bargallo-Rocha, A Armengol-Alonso, Paula Cabrera-Galeana, JP Melo-Morin
Publikováno v:
Cancer Research. 79:P2-07
Background: Breast cancer in Mexico is the first cause of mortality due to malignant tumors among women. The five-year overall survival among Mexican breast cancer patients (MexBCP)treated at governmental facilities is about 75-80% as a result of an
Publikováno v:
Cancer Research. 79:P5-13
Introduction. Public health insurance called Seguro Popular (SP) for breast cancer treatment (BCT) was instituted in Mexico in 2007. Our third level center was enrolled until 2011. SP covers systemic BCT (WHO 20th model list essential medicines). The
Autor:
Jesus Antonio Viana Rojas, Juan Manuel Lopez Quijano, Alejandra Armengol Alonso, Jennifer Armenta Rodriguez
Publikováno v:
JACC: CardioOncology. 4:S17
Publikováno v:
European Heart Journal - Cardiovascular Imaging. 21
A cohort of patients with breast cancer HER2 positive are exposed to chemotherapy with cardiotoxic drugs like anthracyclines (A) and trastuzumab (T). The decrease in longitudinal strain is a helpful tool to predict clinical cardiotoxicity. The purpos